Phototoxicity of Half-Sandwich Rhodium(III) Complexes with Anthracene and Biphenyl Substituents toward Mammalian Cancer Cells and Multicellular Tumor Spheroids

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL
Petra Andršová, Jitka Prachařová, Vojtěch Novohradský, Slavomíra Šterbinská, Pavel Štarha, Jana Kašpárková, Viktor Brabec
{"title":"Phototoxicity of Half-Sandwich Rhodium(III) Complexes with Anthracene and Biphenyl Substituents toward Mammalian Cancer Cells and Multicellular Tumor Spheroids","authors":"Petra Andršová, Jitka Prachařová, Vojtěch Novohradský, Slavomíra Šterbinská, Pavel Štarha, Jana Kašpárková, Viktor Brabec","doi":"10.1021/acs.jmedchem.5c01406","DOIUrl":null,"url":null,"abstract":"We report the synthesis and characterization of three half-sandwich rhodium(III) complexes incorporating anthracene and biphenyl moieties to investigate their photobiological activity. Complexes <b>1</b> and <b>2</b>, bearing anthracene-based Schiff base ligand, displayed pronounced phototoxicity upon blue-light irradiation, with complex <b>2</b> achieving a phototoxicity index of 144 in A375 melanoma cells. In contrast, complex <b>3</b>, lacking the anthracene unit, was photoinactive. Photoactivation of complexes <b>1</b> and <b>2</b> induced −N═CH– Schiff bond cleavage, releasing anthracene-9-carbaldehyde, as confirmed by UV–vis and mass spectrometry. Blue light also enabled catalytic oxidation of NADH to NAD<sup>+</sup>. Mechanistic studies revealed oncosis-like cell death mediated by reactive oxygen species. Both complexes retained activity in 3D tumor spheroids, demonstrating efficient tissue penetration. These results identify anthracene-functionalized rhodium(III) complexes as promising candidates for photodynamic therapy and provide, to our knowledge, the first detailed mechanistic insight into photopotentiation in half-sandwich rhodium systems.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"1 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.5c01406","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

We report the synthesis and characterization of three half-sandwich rhodium(III) complexes incorporating anthracene and biphenyl moieties to investigate their photobiological activity. Complexes 1 and 2, bearing anthracene-based Schiff base ligand, displayed pronounced phototoxicity upon blue-light irradiation, with complex 2 achieving a phototoxicity index of 144 in A375 melanoma cells. In contrast, complex 3, lacking the anthracene unit, was photoinactive. Photoactivation of complexes 1 and 2 induced −N═CH– Schiff bond cleavage, releasing anthracene-9-carbaldehyde, as confirmed by UV–vis and mass spectrometry. Blue light also enabled catalytic oxidation of NADH to NAD+. Mechanistic studies revealed oncosis-like cell death mediated by reactive oxygen species. Both complexes retained activity in 3D tumor spheroids, demonstrating efficient tissue penetration. These results identify anthracene-functionalized rhodium(III) complexes as promising candidates for photodynamic therapy and provide, to our knowledge, the first detailed mechanistic insight into photopotentiation in half-sandwich rhodium systems.

Abstract Image

含蒽和联苯取代基的半夹层铑(III)配合物对哺乳动物癌细胞和多细胞肿瘤球体的光毒性
我们报道了三种含蒽和联苯的半夹心铑配合物的合成和表征,并研究了它们的光生物活性。含有蒽基希夫碱配体的配合物1和2在蓝光照射下表现出明显的光毒性,其中配合物2在A375黑色素瘤细胞中达到144的光毒性指数。相反,配合物3,缺乏蒽单元,是光无活性的。配合物1和2的光活化诱导−N = CH - Schiff键断裂,释放出蒽-9-乙醛,经UV-vis和质谱分析证实。蓝光也能催化NADH氧化为NAD+。机制研究揭示了活性氧介导的肿瘤样细胞死亡。这两种复合物在三维肿瘤球体中都保持活性,显示出有效的组织穿透。这些结果确定了蒽功能化铑(III)配合物是光动力治疗的有希望的候选者,并提供了,据我们所知,第一个详细的机制了解半夹层铑系统的光电位。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信